Impulse Pharma Private Limited, a active private limited company, was established on 28 October 2002 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2002PTC137705. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.
It upholds a compliant status. Employing 100 professional, Its leadership includes Swapnil Vishwasrao Patil (Director), Digambar Jaikishan Zawar (Director), Anil Yashwantrao Patil (Director). Past directors included Narendra Chaitram Patil, Ashok Askaran Jain, Rajendra Ratilal Chavhan. It holds ₹20.00 Cr open charges and ₹25.71 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at J-201 Midctarapur Boiser, Thane, Maharashtra, 401506.
U24230MH2002PTC137705
137705
28 October 2002
₹5.00 Cr
₹5.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Impulse Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapnil Vishwasrao Patil | Director | 23 Mar 2010 | Current |
| Digambar Jaikishan Zawar | Director | 28 Oct 2002 | Current |
| Anil Yashwantrao Patil | Director | 23 Mar 2010 | Current |
| Rajendra Zawar | Managing Director | 28 Apr 2016 | Current |
| Niraj Rajendra Zawar | Director | 22 Feb 2023 | Current |
| Pushkar Digambar Zawar | Director | 28 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Mar 2010 | Past |
| Pramod Abcsdd | Director | 28 Apr 2016 | Past |
| Pramod Abcsdd | Director | 27 Feb 2014 | Past |
| Pramod Abcsdd | Director | 11 Oct 2010 | Past |
| Pramod Abcsdd | Director | 21 Feb 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Impulse Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 11.84% increase. The company also saw a substantial improvement in profitability, with a 13.42% increase in profit. The company's net worth Soared by an impressive increase of 17.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Impulse Pharma had a promoter holding of 87.40% and a public holding of 12.60%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹200,000,000.00
₹257,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2021 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 12 Sep 2017 | Axis Bank Limited | ₹5.00 Cr | Satisfied |
| 20 Mar 2013 | Others | ₹11.95 Cr | Satisfied |
| 21 Dec 2006 | Bank Of Maharashtra | ₹3.00 Cr | Satisfied |
| 19 Dec 2006 | Bank Of Maharashtra | ₹2.88 Cr | Satisfied |
Explore comprehensive loan charge details -
Impulse Pharma has a workforce of 100 employees as of Sep 22, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Impulse Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impulse Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited of Rs. 20.00 Cr registered on 09 Jul 2021 with Charge ID 100471711 was modified on 30 Sep 2024. was documented.
The activity Impulse Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Impulse Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge registered on 20 Mar 2013 via Charge ID 10425603 with Others was fully satisfied on 01 Aug 2023. was completed.
The activity Pushkar Digambar Zawar was appointed as a Director was appointed as a Director on 28 Mar 2023 & has been associated with this company since 2 years 8 months . was completed.
The activity Niraj Rajendra Zawar was appointed as a Director was appointed as a Director on 22 Feb 2023 & has been associated with this company since 2 years 9 months . was completed.
The CIN of Impulse Pharma Private Limited is U24230MH2002PTC137705.
Impulse Pharma Private Limited is headquartered at J-201 Midctarapur Boiser, Thane, Maharashtra, 401506.
Impulse Pharma Private Limited was incorporated on 28 October 2002.
The current directors of Impulse Pharma Private Limited are
The primary industry of Impulse Pharma Private Limited is Manufacturing.
Impulse Pharma Private Limited is unlisted.
The authorized capital of Impulse Pharma Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.
The compliance status of Impulse Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX